Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer


Kurt E., Kurt M. , Kanat O., Cetintas S. , Aygun S., Palazoglu J., ...More

TUMORI, vol.92, no.6, pp.481-486, 2006 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 92 Issue: 6
  • Publication Date: 2006
  • Doi Number: 10.1177/030089160609200603
  • Title of Journal : TUMORI
  • Page Numbers: pp.481-486

Abstract

Aims and background: To evaluate the efficacy and tolerability of a new treatment approach including induction chemotherapy (CT) and concurrent chemoradiotherapy (CRT) in unresectable, locally advanced pancreatic cancer (LAPC).